Corporate has the worst of communications and next to zero on shareholder fiduciaries IMO. Furthermore, possibly one or more board members that's garnered or negotiated financial placements at generous pricing to a specific individual. The value performance on ROI here isn't there. Outside of the general sector getting interests, I don't see corporate having any intentions on effectual communications. I was invested here and divested of late, until possibly later in the year or further disclosures of values. Don't hold your breath. Currently trading around cash value but nothing in regards to realized or potential efficacy onlf Bryostatin. The only positive is a low and tight share structures. However, an extremely high beta volatility.
Good luck to all.